Skip to content
sugarisadrug.com
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

Month: June 2026

3061-LB: Combination Treatment of Oral Small Molecule GLP-1 Receptor Agonist Aleniglipron and Small Molecule Amylin Receptor Agonist ACCG-2671 Demonstrated Additional Weight Loss than Monotreatment in Obese NHPs

June 20, 2026 by sugaradmin

Introduction and Objective: GLP-1 receptor activation and amylin receptor activation are two complementary mechanisms of action for obesity treatments. Combination therapy of long-acting peptides semaglutide and cagrilintide have demonstrated enhanced efficacy over single agents for obesity treatment in clinical trials. Small molecules offer potential advantages over peptides, including scalability, room temperature shipping and storage, and […]

Read More
DiabetesLeave a Comment on 3061-LB: Combination Treatment of Oral Small Molecule GLP-1 Receptor Agonist Aleniglipron and Small Molecule Amylin Receptor Agonist ACCG-2671 Demonstrated Additional Weight Loss than Monotreatment in Obese NHPs

1763-P: Impact of Short-Term Intensive De-escalation Therapy on Long-Term Regimen Simplification in Poorly Controlled Type 2 Diabetes: A National Multicenter, Prospective, Randomized Trial

June 20, 2026 by sugaradmin

Introduction and Objective: To explore whether short-term intensive glucose control can minimize the escalation of treatment in poorly controlled type 2 diabetes.Methods: Patients with poorly controlled type 2 diabetes despite receiving two or more hypoglycemic agents were randomly assigned to three intensive glucose control groups, with a 36-week core period followed by a 24-week extension. […]

Read More
DiabetesLeave a Comment on 1763-P: Impact of Short-Term Intensive De-escalation Therapy on Long-Term Regimen Simplification in Poorly Controlled Type 2 Diabetes: A National Multicenter, Prospective, Randomized Trial

2335-P: Metabolomic Analysis Reveals That Prediabetes Subgroups Have Different Likelihoods of T2D Onset: A Definition, Etiology, and Function: Integration to Enhance T2D Treatment (DEFINE-T2D) Consortium Analysis

June 20, 2026 by sugaradmin

Introduction and Objective: Patients with T2D can be clustered into distinct etiologic subgroups, but it is not clear if the same is true for those with prediabetes (preDM). As metabolites mark the onset of T2D prior to clinical thresholds, we clustered individuals with preDM by preDM-related metabolites and examined subgroups for long-term T2D risk.Methods: Data […]

Read More
DiabetesLeave a Comment on 2335-P: Metabolomic Analysis Reveals That Prediabetes Subgroups Have Different Likelihoods of T2D Onset: A Definition, Etiology, and Function: Integration to Enhance T2D Treatment (DEFINE-T2D) Consortium Analysis

2126-P: Glycemia Risk Index to Characterize Pediatric Type 1 Diabetes Population

June 20, 2026 by sugaradmin

Introduction and Objective: T1D population health requires synthesizing multiple data points. GRI summarizes severity-weighted hypo/hyperglycemia into zone categories. We assessed whether GRI can be used to characterize a pediatric cohort in relation to CGM targets.Methods: We analyzed up to 24 months of CGM data in 225 children with T1D and calculated GRI in consecutive 14-day […]

Read More
DiabetesLeave a Comment on 2126-P: Glycemia Risk Index to Characterize Pediatric Type 1 Diabetes Population

2384-P: Mortality in a Contemporary Type 1 Diabetes Cohort: The CACTI Study

June 20, 2026 by sugaradmin

Introduction and Objective: All-cause mortality has been on the decline among people with type 1 diabetes (T1D). Despite this trend, excess mortality remains high among people with T1D compared to those without T1D. We examined the all-cause and cause-specific mortality in a contemporary T1D cohort and explored factors that influenced mortality.Methods: Participants in the Coronary […]

Read More
DiabetesLeave a Comment on 2384-P: Mortality in a Contemporary Type 1 Diabetes Cohort: The CACTI Study

1987-P: Real-World Gains Evident for Eye Exams for Diabetes in Rural and Urban Clinics with Use of Autonomous AI

June 20, 2026 by sugaradmin

Introduction and Objective: Annual eye examinations for diabetes (EEDs) are essential for early detection of diabetic retinopathy, yet adherence remains suboptimal, particularly in rural communities where access to eye care is limited. Autonomous AI systems offer a scalable approach to expand patient access at the point of care. We evaluated the real-world impact of LumineticsCoreâ„¢, […]

Read More
DiabetesLeave a Comment on 1987-P: Real-World Gains Evident for Eye Exams for Diabetes in Rural and Urban Clinics with Use of Autonomous AI

2139-P: Whey Protein Preload Reduces Postprandial Glucose Excursions in Pregnancy: Results from a Randomized Pilot Study

June 20, 2026 by sugaradmin

Introduction and Objective: Rapid postprandial glucose rises during pregnancy may adversely affect offspring health, while practical dietary advice for gestational diabetes remains limited. In type 2 diabetes, premeal whey protein (WP) reduces postprandial blood glucose. We investigated whether preprandial WP attenuates glucose excursions after carbohydrate intake in pregnant women and explored underlying mechanisms.Methods: In this […]

Read More
DiabetesLeave a Comment on 2139-P: Whey Protein Preload Reduces Postprandial Glucose Excursions in Pregnancy: Results from a Randomized Pilot Study

1112-OR: Intersectional Viral Mapping Reveals a Functional PVH MC4R -> PBN MC4R Neurocircuit for Glycemic Control

June 20, 2026 by sugaradmin

Introduction and Objective: PVHMC4R and PBNMC4R neurons are central to the regulation of energy intake and glucose metabolism, yet the neurocircuit mechanisms underlying glycemic control at these neural nodes remain unclear. Here, we investigated whether a PVHMC4R → PBNMC4R neurocircuit contributes to glucoregulation using an intersectional viral mapping approach.Methods: To anatomically define this pathway, we […]

Read More
DiabetesLeave a Comment on 1112-OR: Intersectional Viral Mapping Reveals a Functional PVH MC4R -> PBN MC4R Neurocircuit for Glycemic Control

2136-P: Gestational Circadian Disruption Impairs Glucose Metabolism in Adult Offspring Mice

June 20, 2026 by sugaradmin

Introduction and Objective: Lifestyle-related circadian disruption, including night-shift work, increases susceptibility to obesity and type 2 diabetes. However, the long-term effects of maternal circadian misalignment during pregnancy on metabolic health of adult offspring remain unclear. We investigated whether gestational circadian disruption, modeled using a short-day (SD) light cycle, programs offspring for metabolic dysfunction.Methods: Pregnant C57BL/6J […]

Read More
DiabetesLeave a Comment on 2136-P: Gestational Circadian Disruption Impairs Glucose Metabolism in Adult Offspring Mice

1641-P: Patterns of Four-Year Weight Change and Reversion of Prediabetes in Middle-Aged and Older Adults with Overweight or Obesity

June 20, 2026 by sugaradmin

Introduction and Objective: Reversion to normoglycemia is increasingly recognized as a key goal in pre-diabetes management. Weight loss is a vital strategy to facilitate prediabetes reversion. This study assessed the association of weight change patterns with prediabetes reversion.Methods: Data were from the China Health and Retirement Longitudinal Study Waves 1-3 (2011, 2013, and 2015). Participants […]

Read More
DiabetesLeave a Comment on 1641-P: Patterns of Four-Year Weight Change and Reversion of Prediabetes in Middle-Aged and Older Adults with Overweight or Obesity

Posts navigation

Older posts
Newer posts

Recent Posts

  • 1027-OR: Differences in Thymocyte Development in Human Immune System Mice Derived from Type 1 Diabetic and Healthy Control Hematopoietic Stem Cells
  • 2710-LB: Lipolysis Inhibition Induces Alterations in the Proteomic Landscape of Serum from Mice Exposed to Electronic Cigarettes
  • 1874-P: Closed-Loop Technology in Acute Care: A Systematic Review and Meta-Analysis
  • 2709-LB: Sustained Hyperglycemia Alters Endothelial Mechanical Organization over Time
  • 2479-P: Synergistic Metabolic and Hepatic Benefits of Dorzagliatin and Resmetirom in MASLD Mice

Recent Comments

  • A WordPress Commenter on SUCROSE: “PURE” ENERGY AT A PRICE

Archives

  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • November 2024
  • October 2024
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • May 2017

Categories

  • Celebrity Health
  • Diabetes
  • Food Choices
  • Fructose
  • General Sugar
  • Glucose
  • Health News
  • Insulin
  • Mental Health
  • Natural Unrefined Sugar
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Sucrose
  • Sugar Science

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

© 2026 Sugar is a DRUG | Sugar Addiction Awareness